It is worth noting that about 30% of Kras-mutated NSCLC exhibit lower PD-L1 expression and less tumour-killing immune cell invasion due to SKT11/LKB11 co-mutation, which may lead to poor ICIs efficacy [111, 112]. Here, CD274 is linked to neoplasm.